Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma

Reference

• Abbad S, Cheng W, Waddad AY, et al. (2015). Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate. Int J Nanomedicine 2015:305–20.
   Google Scholar
• Allam AN, Hamdallah SI, Abdallah OY. (2017). Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. Int J Nanomedicine 12:4733–45.
   PubMed Web of Science ®Google Scholar
• Ao M, Xiao X, Ao Y. (2018). Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer. Braz J Med Biol Res 51:1.
   PubMed Web of Science ®Google Scholar
• Baeza A, Ruiz-Molina D, Vallet-Regí M. (2017). Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks. Expert Opin Drug Deliv 14:783–96.
   PubMed Web of Science ®Google Scholar
• Bian R, Wang T, Zhang L, et al. (2015). A combination of tri-modal cancer imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles. Biomater Sci 3:1270.
   PubMed Web of Science ®Google Scholar
• Gong Y, Yin JY, Tong BD, et al. (2017). Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation. Oncotarget 8:105126–36.
   PubMedGoogle Scholar
• Hashemi M, Yadegari A, Yazdanpanah G, et al. (2016). Functionalized R9-reduced graphene oxide as an efficient nano-carrier for hydrophobic drug delivery. RSC Adv 6:74072–84.
   Web of Science ®Google Scholar
• Li X, Jia X, Niu H. (2018). Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy. Int J Nanomedicine 13:4107–19.
   PubMed Web of Science ®Google Scholar
• Liang H, He L, Zhou B, et al. (2017). Folate-functionalized assembly of low density lipoprotein/sodium carboxymethyl cellulose nanoparticles for targeted delivery. Colloids Surf B Biointerfaces 156:19.
   PubMed Web of Science ®Google Scholar
• Lin C, Lou B, Zhao J, et al. (2016). Self-assembled micelles of PEG-poly(disulfide carbamate amine) copolymers for intracellular dual-responsive drug delivery. J Mater Chem B 4:902–9.
   PubMed Web of Science ®Google Scholar
• Liu B, Han L, Liu J, et al. (2017). Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer. Int J Nanomedicine 12:955–68.
   PubMed Web of Science ®Google Scholar
• Lv Y, Li J, Chen H, et al. (2017). Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. Int J Nanomedicine 12:4361–70.
   PubMed Web of Science ®Google Scholar
• Meng L-x, Ren Q, Meng Q, et al. (2018). Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artif Cells Nanomed Biotechnol 1–8. doi:10.1080/21691401.2018.1501380.
   Web of Science ®Google Scholar
• Rizwan H, Mohanta J, Si S, Pal A. (2017). Gold nanoparticles reduce high glucose-induced oxidative-nitrosative stress regulated inflammation and apoptosis via tuberin-mTOR/NF-κB pathways in macrophages. Int J Nanomedicine 12:5841–62.
   PubMed Web of Science ®Google Scholar
• Ruff J, Steitz J, Buchkremer A, et al. (2016). Multivalency of PEG-thiol ligands affects the stability of NIR-absorbing hollow gold nanospheres and gold nanorods. J Mater Chem B 4:2828–41.
   PubMed Web of Science ®Google Scholar
• Shi J, Sun M, Sun X, Zhang H. (2016). Near-infrared persistent luminescence hollow mesoporous nanospheres for drug delivery and in vivo renewable imaging. J Mater Chem B 4:7845–51.
   PubMed Web of Science ®Google Scholar
• Silva PD, Francesca M, Aurore F, et al. (2016). Pluronic®P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells. Int J Nanomedicine 11:4479–94.
   PubMed Web of Science ®Google Scholar
• Song Y, Li Y, Xu Q, Liu Z. (2016). Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook. Int J Nanomedicine 12:87–110.
   PubMed Web of Science ®Google Scholar
• Stoffelen C, Staltari-Ferraro E, Huskens J. (2015). Effects of the molecular weight and the valency of guest-modified poly(ethylene glycol)s on the stability, size and dynamics of supramolecular nanoparticles. J Mater Chem B 3:6945–52.
   PubMed Web of Science ®Google Scholar
• Su HT, Li X, Liang DS, Qi XR. (2016). Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity. Oncotarget 7:51535–52.
   PubMed Web of Science ®Google Scholar
• Sui J, Cui Y, Cai H, et al. (2017). Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma. Nanoscale 9:2755–67.
   PubMed Web of Science ®Google Scholar
• Tang D, Zhao X, Yang T, Wang C. (2018). Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy. RSC Adv 8:380–9.
   Web of Science ®Google Scholar
• Thapa RK, Choi JY, Poudel BK, et al. (2016). Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy. Int J Nanomedicine 11:2799–813.
   PubMed Web of Science ®Google Scholar
• Thomas VA, Balthasar JP. (2016). Sorafenib decreases tumor exposure to an anti-carcinoembryonic antigen monoclonal antibody in a mouse model of colorectal cancer. AAPS J 18:923–32.
   PubMed Web of Science ®Google Scholar
• Tol J, Dijkstra JR, Klomp M, et al. (2010). Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. Eur J Cancer 46:1997–2009.
   PubMed Web of Science ®Google Scholar
• Wang C, Bao X, Ding X, et al. (2015). A multifunctional self-dissociative polyethyleneimine derivative coating polymer for enhancing the gene transfection efficiency of DNA/polyethyleneimine polyplexes in vitro and in vivo. Polym Chem 6:780–96.
   Web of Science ®Google Scholar
• Wang C, Chen S, Wang Y, et al. (2018). Lipase-triggered water-responsive “Pandora’s box” for cancer therapy: toward induced neighboring effect and enhanced drug penetration. Adv Mater 30:1706407.
   Web of Science ®Google Scholar
• Wang C, Chen S, Yu Q, et al. (2017). Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells. J Mater Chem B 5:2068–73.
   PubMed Web of Science ®Google Scholar
• Wang J-k, Zhou Y-y, Guo S-j, et al. (2017). Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy. Mater Sci Eng C Mater Biol Appl 76:944–50.
   PubMed Web of Science ®Google Scholar
• Wu C, Gong MQ, Liu BY, et al. (2017). Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance. Colloids Surf B Biointerfaces 149:250–9.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhao Y, Mu X, et al. (2015). A silica-polymer composite nano system for tumor-targeted imaging and p53 gene therapy of lung cancer. J Biomater Sci Polym Ed 26:384–400.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Liu Y, Yang S, et al. (2016). Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment. Colloids Surf B Biointerfaces 141:83–92.
   PubMed Web of Science ®Google Scholar
• Xiong H, Ni J, Jiang Z, et al. (2018). Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumor drug resistance modulation of doxorubicin. Biomater Sci 6:2527–40.
   PubMed Web of Science ®Google Scholar
• Xiong F, Nirupama S, Sirsi SR, et al. (2017). Ultrasound-stimulated drug delivery using therapeutic reconstituted high-density lipoprotein nanoparticles. Nanotheranostics 1:440–9.
   PubMedGoogle Scholar
• Xu H, Wu K, Tian Y, et al. (2016). CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer. Int J Oncol 49:1343–50.
   PubMed Web of Science ®Google Scholar
• Yan J, Wang Y, Jia Y, et al. (2017). Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Biomed Pharmacother 88:374–83.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu T, Qin Y, et al. (2018). A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery. Int J Nanomedicine 13:1281–93.
   PubMed Web of Science ®Google Scholar
• Yesylevskyy SO, Ramseyer C, Savenko M, et al. (2018). Low-density lipoproteins and human serum albumin as carriers of squalenoylated drugs: insights from molecular simulations. Mol Pharm 15:585–91.
   PubMed Web of Science ®Google Scholar
• Zhang N, Li S, Hua H, et al. (2016). Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer. Int J Pharm 513:376–86.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang T, Mu S, et al. (2017). Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy. Nanomedicine 12:911–25.
   PubMed Web of Science ®Google Scholar
• Zhao X, Tang D, Yang T, Wang C. (2018). Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system. Colloids Surf B Biointerfaces 170:355–63.
   PubMed Web of Science ®Google Scholar
• Zhu WJ, Yang SD, Qu CX, et al. (2017). Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor. Int J Nanomedicine 12:3375–93.
   PubMed Web of Science ®Google Scholar